Principia Biopharma secures $12.5M second tranche in Series A financing October 30, 2012 CenterWatch Staff
Shionogi, ViiV Healthcare to commercialize and develop integrase inhibitor portfolio October 30, 2012 CenterWatch Staff
Menarini, Oxford BioTherapeutics to collaborate on portfolio of antibody-based cancer drugs October 30, 2012 CenterWatch Staff
Prezista receives E.C. approval for young children with HIV-1 infection October 26, 2012 CenterWatch Staff